EMRIS Pharma vs ImmuniQ
EMRIS Pharma vs ImmuniQ, compared side by side on 10 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: EMRIS Pharma is on 45/100 and ImmuniQ on 54/100.
Where each one leads
EMRIS Pharma
- agent readiness: 30/100 against 22/100
ImmuniQ
- our overall score: 54/100 against 45/100
At a glance
| Measure | EMRIS Pharma | ImmuniQ |
|---|---|---|
| What it is | Developing topical treatments to prevent and treat skin toxicities from cancer therapies. | Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology. |
| Category | Life Sciences, Oncology, Biotech, MedTech | Life Sciences, Oncology, Patient Care, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Services |
| Founded | 2021 | 2021 |
| Headquarters | Tel Aviv, Israel | Tel Aviv, Israel |
| Status | Active | Inactive |
Size, funding and growth
| Measure | EMRIS Pharma | ImmuniQ |
|---|---|---|
| Employees | 7 | Not published |
| LinkedIn followers | 2,441 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | EMRIS Pharma | ImmuniQ |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 45/100 | 54/100 |
| Traction | 9/100 | 11/100 |
| Team | 60/100 | Not published |
| Search visibility | 34/100 | Not published |
| Quality | 58/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (30/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 10/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | EMRIS Pharma | ImmuniQ |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
EMRIS Pharma vs ImmuniQ: common questions
Which is better, EMRIS Pharma or ImmuniQ?
On our 0-100 score ImmuniQ rates higher (54/100 against 45/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 10 data points above: read the rows that match what you are buying for.
How do EMRIS Pharma and ImmuniQ compare on the numbers?
EMRIS Pharma leads on agent readiness (30/100 against 22/100). ImmuniQ leads on our overall score (54/100 against 45/100).
Read the full EMRIS Pharma review and pricing or the ImmuniQ review and pricing. You can also browse other EMRIS Pharma alternatives we track.

